(imshealth.com): IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the completion of its acquisition by entities created by certain affiliates of TPG Capital, L.P. (‘TPG’) and the CPP Investment Board (“CPPIB”). Pursuant to the terms of the merger agreement, IMS Health’s stockholders are entitled to receive $22.00 in cash, without interest, less any applicable withholding taxes, for each share of IMS Health common stock owned by them. As a result of the merger, IMS Health’s common stock will no longer be listed for trading on the New York Stock Exchange.
Category: Articles
Click here